Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2025 earnings results today.
Revenues increased 3% year-over-year to $12.2 billion.
GAAP net income attributable to Bristol Myers Squibb was $2.2 billion, or $1.08 per share, compared to $1.2 billion, or $0.60 per share, last year. Adjusted EPS was $1.63, down 9% YoY.
For full-year 2025, revenue is expected to be $47.5-48.0 billion. Adjusted EPS is expected to be $6.40-6.60.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key metrics from Kroger’s (KR) Q3 2025 earnings results
The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical
Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights
Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or
HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results
Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel
